Conditions: Nasal Polyps
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 127
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the safety and efficacy of Nasonex® (Mometasone Furoate Nasal Spray(MFNS)) in the treatment of nasal polyps in pediatric subjects between the ages of 6 and less than 18 years old. Safety will be the primary focus of this study.

Detailed description:

Arms:
arm 1: Mometasone Furoate nasal Spray (MFNS) 100 mcg once per day (QD) for subjects 6 to less than 12 years of age arm 2: None arm 3: None arm 4: None arm 5: None arm 6: None arm 7: None arm 8: None

Interventions: intervention 1: Mometasone Furoate Nasal Spray (MFNS) intervention 2: Placebo nasal spray
Intervention descriptions: intervention 1: 100 mcg nasal spray intervention 2: One spray of placebo nasal spray in each nostril once daily for 4 months.

Protocol document: